Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Form 8.3 ALLIANCE PHARMA PLC

17 Apr 2025 13:22

RNS Number : 5088F
Barclays PLC
17 April 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

ALLIANCE PHARMA PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Apr 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

5,741,923

1.06%

1,956,258

0.36%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,063,873

0.20%

5,741,834

1.06%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

6,805,796

1.26%

7,698,092

1.42%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

39,648

0.6420 GBP

1p ordinary

Purchase

14,994

0.6430 GBP

1p ordinary

Sale

43,918

0.6424 GBP

1p ordinary

Sale

35,540

0.6420 GBP

1p ordinary

Sale

14,951

0.6419 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Decreasing Short

12,863

0.6419 GBP

1p ordinary

SWAP

Decreasing Short

23,698

0.6420 GBP

1p ordinary

SWAP

Decreasing Short

42,076

0.6424 GBP

1p ordinary

SWAP

Increasing Short

25,538

0.6420 GBP

1p ordinary

SWAP

Increasing Short

14,994

0.6430 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Apr 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETIRMBTMTABBBA
Date   Source Headline
1st Jul 20204:42 pmRNSTotal Voting Rights
1st Jul 20204:39 pmRNSBlock Listing Six Monthly Return
26th Jun 20206:14 pmRNSDirector Share Purchases
2nd Jun 20203:33 pmRNSNotification of Major Holdings
1st Jun 202011:06 amRNSTotal Voting Rights
29th May 20205:21 pmRNSNotification of Major Holdings
18th May 20202:43 pmRNSResult of AGM
18th May 20207:00 amRNSAGM Statement
11th May 20203:44 pmRNSDirector’s Dealing
1st May 202011:47 amRNSTotal Voting Rights
22nd Apr 20205:00 pmRNSAnnual Report and Notice of AGM
8th Apr 20207:00 amRNSBlock Admission Application
7th Apr 20207:00 amRNSFull Year Results 2019
2nd Apr 20203:53 pmRNSTotal Voting Rights
30th Mar 20207:00 amRNSNotification of Preliminary Results & Analyst Call
23rd Mar 20203:52 pmRNSFCA Moratorium on Publication of Results
3rd Mar 202012:54 pmRNSTotal Voting Rights
4th Feb 20204:45 pmRNSNOTIFICATION OF MAJOR HOLDINGS
3rd Feb 20205:13 pmRNSTotal Voting Rights
22nd Jan 202012:04 pmRNSNotification of Major Holdings
22nd Jan 20207:00 amRNSFull Year Trading Update
6th Jan 20201:58 pmRNSBlock Listing Six Monthly Return
3rd Jan 20207:00 amRNSTotal Voting Rights
2nd Jan 20204:38 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Dec 20194:42 pmRNSGrant of Options to Directors
5th Dec 20195:17 pmRNSNotification of Major Holdings
5th Dec 20193:00 pmRNSDirector's Dealing
3rd Dec 201912:07 pmRNSTotal Voting Rights
27th Nov 20197:00 amRNSReturn of Xonvea Licensing Rights
5th Nov 20193:51 pmRNSTotal Voting Rights
9th Oct 201911:14 amRNSDirector's Dealing
3rd Oct 20197:00 amRNSTotal Voting Rights
24th Sep 20197:00 amRNSInterim Results
3rd Sep 20193:26 pmRNSTotal Voting Rights
5th Aug 20197:00 amRNSNotification of Interim Results
2nd Aug 201910:04 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSHalf Year Trading Update
1st Jul 201912:39 pmRNSTotal Voting Rights
1st Jul 20198:00 amRNSBlock Listing Six Monthly Return
1st Jul 20197:00 amRNSDirectorate Change
4th Jun 201911:58 amRNSTotal Voting Rights
23rd May 201910:30 amRNSResult of 2019 AGM
23rd May 20197:15 amRNSAGM Statement
23rd May 20197:15 amRNSComment on CMA Statement of Objections
1st May 20193:53 pmRNSTotal Voting Rights
16th Apr 201912:05 pmRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSMarketing Authorisation for Xonvea in Ireland
26th Mar 20197:00 amRNSFull Year Results
26th Feb 20197:00 amRNSNotification of Preliminary Results
4th Feb 20193:40 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.